Efficacy and Prognosis of Adjuvant Argatroban Treatment in Acute Ischemic Stroke Patients with Early Neurological Deterioration

阿加曲班 医学 阿司匹林 内科学 冲程(发动机) 巴曲酶 纤维蛋白原 凝血酶 血小板 机械工程 工程类
作者
Shengyu Xu,Wenjun Zhang,Yan Zhang,Xu Zhang,Ting Wu
出处
期刊:Discovery Medicine [Discovery Medicine]
卷期号:35 (175): 185-185 被引量:2
标识
DOI:10.24976/discov.med.202335175.19
摘要

The therapeutic outcomes for acute ischemic stroke (AIS) with early neurological deterioration (END) are adverse. Argatroban is a novel direct thrombin inhibitor, which is safe in the treatment of AIS, but its efficacy is controversial. This study sought to assess the therapeutic effect of argatroban as an adjunct to aspirin in the treatment of AIS patients with END. Patients' prognosis for the presence of END was also evaluated.Overall, 166 AIS patients with END were included in the study from June 2018 to June 2021 in The Affiliated Zhangjiagang Hospital of Soochow University. Patients were divided in the control group (aspirin alone) and the study group (aspirin combined with argatroban). General data of the patients were collected. Clinical indexes such as the modified Edinburgh-Scandinavian stroke scale (MESSS), and the serum fibrinogen (FIB) and neuropeptide Y (NPY) levels before and after treatment were also collected. Correlations between prognosis and general data, and FIB and NPY levels in AIS patients with END were analyzed by multivariate logistic regression. The performance of FIB and NPY levels in predicting patients' prognosis was further analyzed using receiver operating characteristic (ROC) curves.There was no significant difference in the general data, such as sex, age, course of disease and basic diseases between the 2 groups. After treatment, the MESSS score (13.08 ± 3.24 vs. 16.48 ± 3.32, p < 0.001), serum FIB level (2.72 ± 0.81 vs. 3.52 ± 0.71, p < 0.001), and NPY level (121.28 ± 17.34 vs. 152.09 ± 18.25, p < 0.001) of the study group was significantly lower than that of the control group. A further analysis revealed that the serum FIB (OR, odds ratio = 2.296, 95% confidence interval, CI: 1.437-3.669, p = 0.001) and NPY (OR = 1.020, 95% CI: 1.002-1.039, p = 0.031) levels were independent risk factors of patients' prognosis for the presence of END.Aspirin combined with argatroban significantly improved neurological impairment of AIS patients with END, which is worthy of clinical application.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
丰富的乐瑶完成签到 ,获得积分10
刚刚
1秒前
廖述祥完成签到,获得积分10
1秒前
2秒前
仙笛童神发布了新的文献求助10
2秒前
3秒前
tanrui完成签到,获得积分10
4秒前
心灵美的石头完成签到,获得积分10
5秒前
未来可期发布了新的文献求助10
5秒前
陆家麟发布了新的文献求助10
6秒前
CodeCraft应助仙笛童神采纳,获得10
7秒前
科研小辣鸡完成签到,获得积分10
8秒前
yaro完成签到,获得积分10
8秒前
文静的柚子完成签到,获得积分10
9秒前
10秒前
12秒前
搜集达人应助LDD采纳,获得10
12秒前
Youngen完成签到,获得积分10
13秒前
若狂完成签到,获得积分10
13秒前
zxh656691发布了新的文献求助10
15秒前
WIL发布了新的文献求助10
17秒前
18秒前
吹吹晚风完成签到,获得积分10
20秒前
会飞的流氓兔完成签到 ,获得积分10
21秒前
研友_LJGXgn完成签到,获得积分10
21秒前
24秒前
情怀应助WIL采纳,获得10
25秒前
zjkzh完成签到,获得积分10
27秒前
迷人耗子精完成签到,获得积分10
28秒前
28秒前
30秒前
隐形曼青应助冰琪采纳,获得10
31秒前
陌路完成签到,获得积分10
31秒前
32秒前
李明月完成签到,获得积分10
33秒前
xiutang完成签到 ,获得积分10
33秒前
rxy发布了新的文献求助50
35秒前
helpme完成签到,获得积分10
37秒前
LDD发布了新的文献求助10
37秒前
纯简发布了新的文献求助10
38秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3967482
求助须知:如何正确求助?哪些是违规求助? 3512759
关于积分的说明 11164944
捐赠科研通 3247740
什么是DOI,文献DOI怎么找? 1794021
邀请新用户注册赠送积分活动 874785
科研通“疑难数据库(出版商)”最低求助积分说明 804517